D&O ongoing disclosure – Paul Dalla Lana

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Vital Healthcare Property Trust
Date this disclosure made:
5-Oct-20
Date of last disclosure:
28-Aug-20
Director or senior manager giving disclosure
Full name(s):
Paul Dalla Lana
Name of listed issuer:
Vital Healthcare Property Trust
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:Director of NorthWest Healthcare Properties
Management Limited (Manager of Vital
Healthcare Property Trust)
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Ordinary units in Vital Healthcare Property
Trust
Nature of the affected relevant interest(s):Paul Dalla Lana has a relevant interest in
ordinary units held by (a) NWI NZ
Management Company Limited (beneficial
owner), (b) NWI Healthcare Properties LP
(beneficial owner), (c) NorthWest NZ
Finance Holdings Limited (beneficial owner)
and (d) NorthWest Healthcare Properties
Management Limited (beneficial owner) as a
result of each of those entities being wholly
owned subsidiaries of NorthWest Healthcare
Properties REIT, of which Paul Dalla Lana is
the Chairman of the Board of Trustees and
holds an approximate 15.4% interest in.
For that relevant interest-
Number held in class before acquisition or disposal:
116,033,251
Number held in class after acquisition or disposal:
116,883,641
Current registered holder(s):NZGT Security Trustee Limited
(111,923,292), Forsyth Barr Custodians
Limited (1,494,883), NWI Healthcare
Properties LP (50,000) and NorthWest
Healthcare Properties Management Limited
(2,565,076)
Registered holder(s) once transfers are registered:NZGT Security Trustee Limited
(112,743,561), Forsyth Barr Custodians
Limited (1,505,839), NWI Healthcare
Properties LP (50,366) and NorthWest
Healthcare Properties Management Limited
(2,583,875)
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A

Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if
any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable under the
derivative or the value of the derivative is affected by the value of the underlying financial products:
N/A
For that derivative,-
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the
derivative:
N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: One
Details of transactions requiring disclosure-
Date of transaction:24-Sep-20
Nature of transaction: Distribution reinvestment plan
Name of any other party or parties to the transaction (if known):
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If
the consideration was not in cash and cannot be readily by converted into a cash value, describe the
consideration:
2,538,227.06
Number of financial products to which the transaction related:
850,390
If the issuer has a financial products trading policy that prohibits directors or senior managers from
trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the
closed period:
NA
Date of the prior written clearance (if any):
NA
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Ordinary units
Nature of relevant interest:
Paul Dalla Lana has a relevant interest in:
(a) 103,487,151 ordinary units held by NWI
Healthcare Properties LP (as beneficial
owner);
(b) 1,505,839 ordinary units held by NWI NZ
Management Company Limited (as
beneficial owner);
(c) 9,306,776 ordinary units held by
NorthWest NZ Finance Holdings Limited (as
beneficial owner); and
(d) 2,583,875 ordinary units held by
NorthWest Healthcare Properties
Management Limited (as beneficial owner)
For that relevant interest,-
Number held in class:116,883,641
Current registered holder(s):
NZGT Security Trustee Limited
(112,743,561), Forsyth Barr Custodians
Limited (1,505,839), NWI Healthcare
Properties LP (50,366) and NorthWest
Healthcare Properties Management Limited
(2,583,875)
For a derivative relevant interest,-
Type of derivative:NA

Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if
any):
NA
A statement as to whether the derivative is cash settled or physically settled:NA
Maturity date of the derivative (if any):NA
Expiry date of the derivative (if any):NA
The price's specified terms (if any):NA
Any other details needed to understand how the amount of the consideration payable under the
derivative or the value of the derivative is affected by the value of the underlying financial products:
NA
For that derivative relevant interest,-
Parties to the derivative: NA
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the
derivative:
NA
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is
correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
5-Oct-20
Name and title of authorised person:
Bernard Crotty